Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer that had exhibited primary or secondary resistance to prior endocrine therapy
| Affiliation auteurs | Affiliation ok |
| Titre | Abemaciclib in combination with fulvestrant in patients with HR+/HER2-advanced breast cancer that had exhibited primary or secondary resistance to prior endocrine therapy |
| Type de publication | Journal Article |
| Year of Publication | 2019 |
| Auteurs | Foster C., Pivot X., Llombart-Cussac A., Neven P., Lin Y., Kaufman P.A, Sledge JGW |
| Journal | ONCOLOGY RESEARCH AND TREATMENT |
| Volume | 42 |
| Pagination | 289-290 |
| Type of Article | Meeting Abstract |
| ISSN | 2296-5270 |